Menu
GWAS Study

A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.

Zhu Y, Tian J, Peng X et al.

33975060 PubMed ID
GWAS Study Type
1070 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ZY
Zhu Y
TJ
Tian J
PX
Peng X
WX
Wang X
YN
Yang N
YP
Ying P
WH
Wang H
LB
Li B
LY
Li Y
ZM
Zhang M
CY
Cai Y
LZ
Lu Z
NS
Niu S
LY
Li Y
ZR
Zhong R
CJ
Chang J
MX
Miao X
Chapter II

Abstract

Summary of the research findings

Aim: This study aimed to identify the functional genes and genetic variants associated with the prognosis of pancreatic ductal adenocarcinoma (PDAC) and reveal the mechanism underlying their prognostic roles.

518 Han Chinese ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1070
Total Participants
GWAS
Study Type
Yes
Replicated
552 Han Chinese ancestry cases
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.